METHODS AND COMPOSITIONS FOR ENCAPSULATING ACTIVE AGENTS

• US 20100213628A1
• Filed: 02/25/2010
• Published: 08/26/2010
• Est. Priority Date: 12/07/2000
• Status: Abandoned Application

• Current Assignee: President and Fellows of Harvard College (Harvard Corporation)
• Original Assignee: President and Fellows of Harvard College (Harvard Corporation)
• Inventors: Bausch, Andreas R., Dinsmore, Anthony D., Hsu, Ming F., Nikolaides, Michael, Weitz, David A.
• Application Number:
  US12/712,620
• Publication Number:
  US 20100213628A1
• Time in Patent Office: Days
• US Class Current: 264/4.100
• CPC Class Codes: A61K 9/5026 obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
• CPC Class Codes: A61K 9/5089 Processes
• CPC Class Codes: B01J 13/02 Making microcapsules or microballoons for medical preparations A61K9/50

Abstract

Methods for making self-assembled, selectively permeable elastic microscopie structures, referred to herein as colloidosomes, that have controlled pore-size, porosity and advantageous mechanical properties are described. In one form of the invention, a method of forming colloidosomes includes providing particles formed from a biocompatible material in a first solvent and forming an emulsion by adding a first fluid to the first solvent wherein the emulsion is defined by droplets of the first fluid surrounded by the first solvent. The method includes coating the surface of droplet with the particles and the stabilizing the particles on the surface of droplet. The colloidosomes produced typically have a yield strength of at least about 20 Pascals. In certain forms of the invention, the particles are spherical and are formed of a biocompatible polymer. Colloidosomes formed according to the methods described herein are also provided. In one form, a colloidosome includes a shell formed of biocompatible, substantially spherical particles wherein each of the particles are linked to neighboring particles. The shell defines an inner chamber sized for housing a desired active agent and has a plurality of pores extending therethrough. The colloidosomes are structurally stable, typically having a yield strength of at least about 20 Pascals. Colloidal suspension and methods of encapsulating a desired active agent are also described

Claims

1. A method of forming colloidosomes, comprising:

(a) providing particles formed from a material in a first solvent;

(b) forming an emulsion by adding a first fluid to said first solvent, said emulsion defined by droplets of said first fluid surrounded by said first solvent;

(c) coating the surface of said droplets with said particles; and

(d) stabilizing said particles on said surface of said droplet to form colloidosomes having a yield strength of at least about 20 Pascals.

2. The method of claim 1, wherein said first solvent is an aqueous solvent and said first fluid is an organic solvent.

3. The method of claim 1, wherein said first solvent is an organic solvent and said first fluid is an aqueous solvent.

4. The method of claim 1, wherein said first solvent is an organic solvent or an aqueous solvent and said first fluid is a gas.

5. The method of claim 1, wherein said particles are substantially spherical.

6. The method of claim 1, wherein said material is a polymer.

7. The method of claim 6, wherein said polymer is hydrophobic.

8. The method of claim 7, wherein said hydrophobic polymer is polymethylmethacrylate.

9. The method of claim 7, wherein said hydrophobic polymer is polystyrene.

10. The method of claim 7, wherein said hydrophobic polymer is selected from the group consisting of polystyrene, polymethylmethacrylate, polyalkylenes, silica and combinations thereof.

11. The method of claim 7, wherein said polymer is functionalized with an ionic functional group.

12. The method of claim 11, wherein said functional group is anionic and is selected from the group consisting of carboxyl and sulfate.

13. The method of claim 1, further comprising transferring said colloidosomes into a second fluid and recovering intact colloidosomes, wherein said second fluid is substantially identical to said first fluid.

14. The method of claim 1, wherein at least about 99% of said colloidosomes remain intact after transferring said colloidosomes from said first solvent into a second solvent substantially the same as said first fluid.

15. The method of claim 1, wherein said stabilizing is performed by mechanically locking at least some adjacent particles by at least partly coalescing said at least some adjacent particles.

19. The method of claim 15, wherein said mechanically locking said at least some adjacent particles by at least partly coalescing said at least some adjacent particles is performed by swelling said particles by adding a second solvent to said first solvent.

20. The method of claim 19, wherein said second solvent is a combination of at least two solvents.

21. The method of claim 15, wherein said mechanically locking at least some adjacent particles by at least partly coalescing said at least some adjacent particles is performed by sintering said at least some adjacent particles which upon cooling form a continuous linkage between said at least some adjacent particles.

22. The method of claim 1, further comprising isolating said colloidosomes by centrifuging said colloidosomes from said first solvent into a second solvent substantially the same as said first fluid.

76. The method of claim 1, wherein said first fluid comprises an active agent.

77. The method of claim 76, wherein said active agent is selected from the group consisting of a chemical agent or biological agent.

78. The method of claim 77, wherein said chemical agent is selected from the group consisting of a drug, a flavoring agent, a fragrance-producing chemical, and a combination thereof.

79. The method of claim 76, wherein said biological agent is a biological macromolecule.

80. The method of claim 79, wherein said macromolecule is selected from the group consisting of a protein, a nucleic acid, a carbohydrate, a lipid and a combination thereof.

81. The method of claim 76, wherein said biological agent is a biological cell.

82. The method of claim 1, wherein the material is biocompatible.

16-18. -18. (canceled)

23-75. -75. (canceled)